Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity
- PMID: 25326387
- PMCID: PMC4256358
- DOI: 10.1074/jbc.M114.598201
Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity
Abstract
Human kallikrein-related peptidase 2 (KLK2) is a tryptic serine protease predominantly expressed in prostatic tissue and secreted into prostatic fluid, a major component of seminal fluid. Most likely it activates and complements chymotryptic KLK3 (prostate-specific antigen) in cleaving seminal clotting proteins, resulting in sperm liquefaction. KLK2 belongs to the "classical" KLKs 1-3, which share an extended 99- or kallikrein loop near their non-primed substrate binding site. Here, we report the 1.9 Å crystal structures of two KLK2-small molecule inhibitor complexes. In both structures discontinuous electron density for the 99-loop indicates that this loop is largely disordered. We provide evidence that the 99-loop is responsible for two biochemical peculiarities of KLK2, i.e. reversible inhibition by micromolar Zn(2+) concentrations and permanent inactivation by autocatalytic cleavage. Indeed, several 99-loop mutants of KLK2 displayed an altered susceptibility to Zn(2+), which located the Zn(2+) binding site at the 99-loop/active site interface. In addition, we identified an autolysis site between residues 95e and 95f in the 99-loop, whose elimination prevented the mature enzyme from limited autolysis and irreversible inactivation. An exhaustive comparison of KLK2 with related structures revealed that in the KLK family the 99-, 148-, and 220-loop exist in open and closed conformations, allowing or preventing substrate access, which extends the concept of conformational selection in trypsin-related proteases. Taken together, our novel biochemical and structural data on KLK2 identify its 99-loop as a key player in activity regulation.
Keywords: 99-Loop; Autolytic Cleavage; Conformational Selection; Crystallography; Enzyme Kinetics; Kallikrein; Prostate Cancer; Serine Protease; Substrate Specificity; Zinc Inhibition.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Figures









References
-
- Frey E. K., Kraut H. (1926) Über einen von der Niere ausgeschiedenen, die Herztätigkeit anregenden Stoff. Hoppe-Seyler's Z. Physiol. Chem. 157, 32–61
-
- Kraut H., Frey E. K., Werle E. (1930) Der Nachweis eines Kreislaufhormons in der Pankreasdrüse. (IV. Mitteilung über dieses Kreislaufhormon) Hoppe-Seyler's Z. Physiol. Chem. 189, 97–106
-
- Rao A. R., Motiwala H. G., Karim O. M. (2008) The discovery of prostate-specific antigen. BJU Int. 101, 5–10 - PubMed
-
- Schedlich L. J., Bennetts B. H., Morris B. J. (1987) Primary structure of a human glandular kallikrein gene. DNA 6, 429–437 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Miscellaneous